Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
AUTL holding history
Autolus Therapeutics plc in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AUTL overviewAll 13F holders of AUTLFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −610,231−100.0% | Sold out | Holders |
| Q2 2025 | 610,231 | $1.39M | 0.1% | +266,284+77.4% | Added | Holders |
| Q1 2025 | 343,947 | $533.1K | 0.1% | +245,052+247.8% | Added | Holders |
| Q4 2024 | 98,895 | $232.4K | <0.1% | −307,663−75.7% | Reduced | Holders |
| Q3 2024 | 406,558 | $1.48M | 0.1% | −204,344−33.4% | Reduced | Holders |
| Q2 2024 | 610,902 | $2.13M | 0.2% | +610,902 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −371,540−100.0% | Sold out | Holders |
| Q1 2022 | 371,540 | $1.55M | 0.1% | −30,000−7.5% | Reduced | Holders |
| Q4 2021 | 401,540 | $2.08M | 0.2% | +3,466+0.9% | Added | Holders |
| Q3 2021 | 398,074 | $2.61M | 0.2% | −75,000−15.9% | Reduced | Holders |
| Q2 2021 | 473,074 | $3.14M | 0.3% | +473,074 | New | Holders |